Surgery in overweight patients with insulinoma: effects on weight loss

References

• Service FJ, McMahon MM, O'Brien PC, et al. Functioning insulinoma–incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991;66:711–719.
   PubMed Web of Science ®Google Scholar
• Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology. 2008;135:1469–1492.
   PubMed Web of Science ®Google Scholar
• Kulke MH, Anthony LB, Bushnell DL, et al. NANETS Treatment Guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas. 2010;39:735–752.
   PubMed Web of Science ®Google Scholar
• De Herder WW, Niederle B, Scoazec JY, et al. Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology. 2006;84:183–188.
   PubMed Web of Science ®Google Scholar
• Tucker ON, Crotty PL, Conlon KC. The management of insulinoma. Br J Surg. 2006;93:264–275.
   PubMed Web of Science ®Google Scholar
• Schultes B, Oltmanns KM, Kern W, et al. Modulation of hunger by plasma glucose and metformin. J Clin Endocrinol Metab. 2003;88:1133–1141.
   PubMed Web of Science ®Google Scholar
• Smith GP, Epstein AN. Increased feeding in response to decreased glucose utilization in the rat and monkey. Am J Physiol. 1969;217:1083–1087.
   PubMed Web of Science ®Google Scholar
• Dewan S, Gillett A, Mugarza JA, et al. Effects of insulin-induced hypoglycaemia on energy intake and food choice at a subsequent testmeal. Diabetes Metab Res Rev. 2004;20:405–410.
   PubMed Web of Science ®Google Scholar
• Skovsø S, Damgaard J, Fels JJ, et al. Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes. Int J Obes (Lond). 2015;39:1531–1538.
   PubMed Web of Science ®Google Scholar
• Liu SC, Tu YK, Chien MN, et al. Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis. Diabetes Obes Metab. 2012;14:810–820.
   PubMed Web of Science ®Google Scholar
• Wong RH, Sul HS. Insulin signaling in fatty acid and fat synthesis: a transcriptional perspective. Curr Opin Pharmacol. 2010;10:684–691.
   PubMed Web of Science ®Google Scholar
• Boukhman MP, Karam JH, Shaver J, et al. Insulinoma-experience from 1950 to 1995. West J Med. 1998;169:98–104.
   PubMedGoogle Scholar
• Nikfarjam M, Warshaw AL, Axelrod L, et al. Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg. 2008;247:165–172.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhan H, Zhang T, et al. Surgical management of patients with insulinomas: result of 292 cases in a single institution. J Surg Oncol. 2011;103:169–174.
   PubMed Web of Science ®Google Scholar
• Vrkljan M, Doko M, Bekić M, et al. Multiple endocrine neoplasia: case report. Acta Clin Croat. 2001;40:209–214.
   Google Scholar
• Ravnik Oblak M, Janež A, Kocijaničič A. Insulinoma induced hypoglycemia in a type 2 diabetic patient. Wien Klin Wochenschr. 2001;113:339–341.
   PubMed Web of Science ®Google Scholar
• Iizuka K, Fujisawa T, Takeda J. Concurrent insulinoma and impaired glucose tolerance suspected as owing to obesity. BMJ Case Reports. 2016; DOI:10.1136/bcr-2015-213793
   Google Scholar
• Ademoğlu E, Ünlütürk U, Ağbaht K, et al. Type 2 diabetes mellitus in a patient with malignant insulinoma manifesting following surgery. Diabet Med. 2012;2:e133–e137.
   Web of Science ®Google Scholar
• Sharma P, Sharma S, Kalhan S, et al. Insulinoma: a comprehensive summary of two cases. J Clin Diagn Res. 2014;8:FD05–FD06.
   PubMedGoogle Scholar
• Popovic V, Micic D, Danjanovic S, et al. Serum leptin and insulin concentrations in patients with insulinoma before and after surgery. Eur J Endocrinol. 1998;138:86–88.
   PubMed Web of Science ®Google Scholar
• Patel SR, Bellary S, Karimzad S, et al. Overweight status is associated with extensive signs of microvascular dysfunction and cardiovascular risk. Sci Rep. 2016;6:32282.
   PubMed Web of Science ®Google Scholar
• WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–163.
   PubMed Web of Science ®Google Scholar
• Service FJ, Natt N. The prolonged fast. J Clin Endocrinol Metab. 2000;85:3973–3974.
   PubMed Web of Science ®Google Scholar
• Belle SH, Berk PD, Courcoulas AP, et al. Reporting weight change: standardized reporting accounting for baseline weight. Surg Obes Relat Dis. 2013;9:782–789.
   PubMed Web of Science ®Google Scholar
• Hatoum IJ, Kaplan LM. Advantages of percent weight loss as a method of reporting weight loss after Roux-en-Y gastric bypass. Obesity (Silver Spring). 2013;21:1519–1525.
   PubMed Web of Science ®Google Scholar
• Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.
   PubMed Web of Science ®Google Scholar
• Kishikawa H, Okada Y, Hirose A, et al. Successful treatment of insulinoma by a single daily dose of octreotide in two elderly female patients. Endocr J. 2006;53:79–85.
   PubMed Web of Science ®Google Scholar
• Jawiarczyk A, Bolanowski M, Syrycka J, et al. A case of insulinoma successfully treated by means of long-acting somatostatin analogue. Proceedings of the 7th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; 2010 Mar 11–12; Berlin. Germany. Neuroendocrinology. 2010: 92. Abstract PP34–35.
   Google Scholar
• Tanaka Y, Funahashi H, Imai T, et al. The effectiveness of administering a minimal dose of octreotide long-term prior to surgery for insulinoma: report of a case. Surg Today. 2000;30:541–543.
   PubMed Web of Science ®Google Scholar
• Kang J, Park JS, Yoon DS, et al. A Study on the Dietary Intake and the Nutritional Status among the Pancreatic Cancer Surgical Patients. Clin Nutr Res. 2016;5:279–289.
   PubMedGoogle Scholar
• Mikamori M, Miyamoto A, Asaoka T, et al. Postoperative changes in body composition after pancreaticoduodenectomy using multifrequency bioelectrical impedance analysis. J Gastrointest Surg. 2016;20:611–618.
   PubMed Web of Science ®Google Scholar
• Pontiroli AE, Alberetto M, Capra F, et al. The glucose clamp technique for the study of patients with hypoglycemia: insulin resistance as a feature of insulinoma. J Endocrinol Invest. 1990;13:241–245.
   PubMed Web of Science ®Google Scholar
• Donnelly R, Connell JM. Insulin resistance: possible role in the aetiology and clinical course of hypertension. Clin Sci. 1992;83:265–275.
   PubMed Web of Science ®Google Scholar
• Reaven GM, Hoffman BB. A role for insulin in the aetiology and course of hypertension? Lancet. 1987;2:435–437.
   PubMed Web of Science ®Google Scholar
• Skrha J, Hilgertova J, Justova V. Insulin action in patients with insulinoma influenced by pharmacological and surgical therapy. Exp Clin Endocrinol. 1993;101:360–364.
   PubMedGoogle Scholar
• Kaul B, Kaur P, Tripathi M, et al. An unusual cause of reversible axonal neuropathy and hypertension in a 10-year-old girl. J Clin Neurosci. 2012;19:1196–1197.
   PubMed Web of Science ®Google Scholar
• Gadiot RP, Biter LU, van Mil S, et al. Long-term results of laparoscopic sleeve gastrectomy for morbid obesity: 5 to 8-year results. Obes Surg. 2017;27:59–63.
   PubMed Web of Science ®Google Scholar
• Hatoum IJ, Blackstone R, Hunter TD, et al. Clinical factors associated with remission of obesity-related comorbidities after bariatric surgery. JAMA Surg. 2016;151:130–137.
   PubMed Web of Science ®Google Scholar
• Gasa M, Salord N, Fortuna AM, et al. Obstructive sleep apnoea and metabolic impairment in severe obesity. Eur Respir J. 2011;38:1089–1097.
   PubMed Web of Science ®Google Scholar
• Sarkhosh K, Switzer NJ, El Hadi M, et al. The impact of bariatric surgery on obstructive sleep apnea: a systematic review. Obes Surg. 2013;23:414–423.
   PubMed Web of Science ®Google Scholar